AKT1 and uterine cancer: Although specific PI3-K inhibitor LY294002 inhibits the growth of uterine cancer cells [8], preliminary experiments indicate that LY294002 does not block the increase of cellular proliferation triggered by low doses of resveratrol (data not shown), suggesting that PI3-K/AKT pathway is not influenced by resveratrol, at least at low doses.